DNTH vs ZBH · rev $17.8M vs P/E 23, rev $4.26B
Dianthus Therapeutics Inc. (DNTH) versus Zimmer Biomet Holdings Inc (ZBH) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Zimmer Biomet Holdings Inc (ZBH) is a medical devices company listed on NYSE.
Latest reported DNTH revenue for 2026-06-30 was $17.8M. Net income was -$91.0M. DNTH currently screens at market cap $4.40B.
Latest reported ZBH revenue for 2026-06-30 was $4.26B. Net income was $436.5M. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
DNTH currently screens at market cap $4.40B. ZBH currently screens at market cap $17.13B and trailing P/E 22.9.
Not investment advice. Open the DNTH and ZBH stock pages for the full models.
Not investment advice.